Abstract:Background and objectives: In multiple sclerosis (MS), immune cells invade the CNS and destroy myelin. Macrophages contribute to demyelination and myelin repair, and their role in each process depends on their ability to acquire specific phenotypes in response to external signals. In this article, we assess whether defects in MS patient macrophage responses may lead to increased inflammation or lack of neuroregenerative effects. Methods: CD14+CD16- monocytes from patients with MS and healthy controls (HCs) were activated in vitro to obtain homeostatic-like, proinflammatory, and proregenerative macrophages. Macrophage activation profiles were assessed through RNA sequencing and metabolomics. Surface molecule expression of CD14, CD16, and HLA-DR and myelin phagocytic capacity were evaluated with flow cytometry. Macrophage supernatant capacity to influence oligodendrocyte precursor cell differentiation toward an astrocytic or oligodendroglia fate was also tested. Results: We observed that MS patient monocytes ex vivo recapitulate their preferential activation toward the CD16+ phenotype, a subset of proinflammatory cells overrepresented in MS lesions. Functionally, MS patient macrophages display a decreased capacity to phagocytose human myelin and a deficit of processing myelin after ingestion. In addition, MS patient macrophage supernatant favors astrocytes over oligodendrocyte differentiation when compared with HC macrophage supernatant. Furthermore, even when exposed to homeostatic or proregenerative stimuli, MS patient macrophages uphold a proinflammatory transcriptomic profile with higher levels of cytokine/chemokine. Of interest, MS patient macrophages exhibit a distinct metabolic signature with a mitochondrial energy metabolism blockage. Transcriptomic data are further substantiated by metabolomics studies that reveal perturbations in the corresponding metabolic pathways. Discussion: Our results show an intrinsic defect of MS patient macrophages, reminiscent of innate immune cell memory in MS, lifting macrophage importance in the disease and as potential therapeutic targets.

CNS macrophage contributions to myelin health

Microglia regulate central nervous system myelin growth and integrity

Microglia regulation of central nervous system myelin health and regeneration

Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair

Microglia: origins, homeostasis, and roles in myelin repair

The roles of microglia and astrocytes in myelin phagocytosis in the central nervous system

Microglia balances hypermyelination and demyelination in the brain

Chronic oligodendrocyte injury in central nervous system pathologies

Clinical implications of myelin regeneration in the central nervous system

Myelin and macrophages in the PNS: An intimate relationship in trauma and disease

Regenerative Capacity of Macrophages for Remyelination

The macrophage: a key player in the pathophysiology of peripheral neuropathies

M2 Microglia and Macrophages Drive Oligodendrocyte Differentiation During CNS Remyelination

Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood

Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis

Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair

Myeloid Cells in the Central Nervous System

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets

Endothelial cells and macrophages as allies in the healthy and diseased brain

Multiple Sclerosis Patient Macrophages Impaired Metabolism Leads to an Altered Response to Activation Stimuli